Altered leucocyte trafficking and suppressed tumour necrosis factor alpha release from peripheral blood monocytes after intra-articular glucocorticoid treatment
J H Steer, D T Ma, L Dusci, G Garas, K E Pedersen, D A Joyce, J H Steer, D T Ma, L Dusci, G Garas, K E Pedersen, D A Joyce
Abstract
Objectives: A generalised transient improvement may follow intra-articular administration of glucocorticoids to patients with inflammatory arthropathy. This may represent a systemic anti-inflammatory effect of glucocorticoid released from the joint, mediated through processes such as altered leucocyte trafficking or suppressed release of pro-inflammatory cytokines. Patients, who had received intra-articular injections of glucocorticoids were therefore studied for evidence of these two systemic effects.
Methods: Patients with rheumatoid arthritis were studied. Peripheral blood leucocyte counts, tumour necrosis factor alpha (TNF alpha) release by peripheral blood monocytes, blood cortisol concentrations, and blood methylprednisolone concentration were measured for 96 hours after intra-articular injection of methylprednisolone acetate.
Results: Measurable concentrations of methylprednisolone were present in blood for up to 96 hours after injection. Significant suppression of the hypothalamic-pituitary-adrenal axis persisted throughout this time. Altered monocyte and lymphocyte trafficking, as evidenced by peripheral blood monocytopenia and lymphopenia, was apparent by four hours after injection and resolved in concordance with the elimination of methylprednisolone. Granulocytosis was observed at 24 and 48 hours. Release of TNF alpha by endotoxin stimulated peripheral blood monocytes was suppressed at four hours and thereafter. Suppression was maximal at eight hours and was largely reversed by the glucocorticoid antagonist, mifepristone.
Conclusions: After intra-articular injection of methylprednisolone, blood concentrations of glucocorticoid are sufficient to suppress monocyte TNF alpha release for at least four days and to transiently alter leucocyte trafficking. These effects help to explain the transient systemic response to intra-articular glucocorticoids. Suppression of TNF alpha is principally a direct glucocorticoid effect, rather than a consequence of other methylprednisolone induced changes to blood composition.
Figures
References
- Eur J Clin Invest. 1994 Nov;24(11):773-7
- Circulation. 1997 Jul 1;96(1):295-301
- J Exp Med. 1970 Mar 1;131(3):429-42
- J Exp Med. 1973 Jan 1;137(1):10-21
- Br J Haematol. 1973 Mar;24(3):275-85
- J Clin Invest. 1974 Jan;53(1):240-6
- J Clin Invest. 1975 Jan;55(1):22-32
- Ann Rheum Dis. 1981 Dec;40(6):571-4
- Hybridoma. 1987 Jun;6(3):305-11
- Arthritis Rheum. 1988 Mar;31(3):315-24
- Br J Clin Pharmacol. 1988 Dec;26(6):709-13
- Lymphokine Res. 1990 Summer;9(2):147-53
- Am J Respir Cell Mol Biol. 1992 Jan;6(1):75-81
- Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):9991-5
- Mol Pharmacol. 1993 Feb;43(2):176-82
- J Clin Pharmacol. 1993 Feb;33(2):115-23
- Rheumatol Int. 1993;12(6):217-20
- Endocrinology. 1993 Nov;133(5):1922-33
- Ann Intern Med. 1993 Dec 15;119(12):1198-208
- BMJ. 1993 Nov 20;307(6915):1329-30
- J Neuroimmunol. 1994 Feb;50(1):71-6
- Arthritis Rheum. 1995 Feb;38(2):151-60
- Am J Clin Pathol. 1995 Feb;103(2):167-70
- J Leukoc Biol. 1995 Mar;57(3):379-86
- J Investig Med. 1995 Feb;43(1):68-77
- Curr Opin Rheumatol. 1995 May;7(3):229-34
- Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8016-20
- Genet Anal. 1995 Mar;12(1):39-43
- Endocrinology. 1995 Sep;136(9):4133-8
- Am J Respir Cell Mol Biol. 1996 Jul;15(1):97-106
- Eur J Immunol. 1996 Nov;26(11):2758-63
- J Immunol. 1997 Apr 15;158(8):3836-44
- J Immunol. 1997 May 15;158(10):5007-16
- Br J Clin Pharmacol. 1997 Apr;43(4):383-9
- Circ Shock. 1994 Aug;43(4):179-84
Source: PubMed